Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Anaplastic Lymphoma Kinase
/ genetics
B7-H1 Antigen
/ genetics
Biomarkers, Tumor
/ genetics
Carcinoma, Non-Small-Cell Lung
/ diagnosis
Circulating Tumor DNA
ErbB Receptors
/ genetics
High-Throughput Nucleotide Sequencing
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
Liquid Biopsy
Lung Neoplasms
/ diagnosis
Membrane Glycoproteins
/ genetics
Neoplastic Cells, Circulating
Polymerase Chain Reaction
Protein-Tyrosine Kinases
/ genetics
Proto-Oncogene Proteins
/ genetics
Proto-Oncogene Proteins B-raf
/ genetics
Proto-Oncogene Proteins c-met
/ genetics
Proto-Oncogene Proteins c-ret
/ genetics
Receptor, ErbB-2
/ genetics
Receptor, trkA
/ genetics
Receptor, trkB
/ genetics
Receptor, trkC
/ genetics
Societies, Medical
Spain
ALK
BRAF
Biomarkers
EGFR
Non-small-cell lung cancer
PD-L1
ROS1
Journal
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
13
06
2019
accepted:
24
09
2019
pubmed:
11
10
2019
medline:
26
3
2021
entrez:
11
10
2019
Statut:
ppublish
Résumé
In 2011 the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP) started a joint project to establish guidelines on biomarker testing in patients with advanced non-small-cell lung cancer (NSCLC) based on current evidence. As this field is constantly evolving, these guidelines have been updated, previously in 2012 and 2015 and now in 2019. Current evidence suggests that the mandatory tests to conduct in all patients with advanced NSCLC are for EGFR and BRAF mutations, ALK and ROS1 rearrangements and PD-L1 expression. The growing need to study other emerging biomarkers has promoted the routine use of massive sequencing (next-generation sequencing, NGS). The coordination of every professional involved and the prioritisation of the most suitable tests and technologies for each case remains a challenge.
Identifiants
pubmed: 31598903
doi: 10.1007/s12094-019-02218-4
pii: 10.1007/s12094-019-02218-4
pmc: PMC7260262
doi:
Substances chimiques
B7-H1 Antigen
0
Biomarkers, Tumor
0
CD274 protein, human
0
Circulating Tumor DNA
0
Membrane Glycoproteins
0
NTRK1 protein, human
0
NTRK3 protein, human
0
Proto-Oncogene Proteins
0
ALK protein, human
EC 2.7.10.1
Anaplastic Lymphoma Kinase
EC 2.7.10.1
EGFR protein, human
EC 2.7.10.1
ERBB2 protein, human
EC 2.7.10.1
ErbB Receptors
EC 2.7.10.1
MET protein, human
EC 2.7.10.1
Protein-Tyrosine Kinases
EC 2.7.10.1
Proto-Oncogene Proteins c-met
EC 2.7.10.1
Proto-Oncogene Proteins c-ret
EC 2.7.10.1
RET protein, human
EC 2.7.10.1
ROS1 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Receptor, trkA
EC 2.7.10.1
Receptor, trkB
EC 2.7.10.1
Receptor, trkC
EC 2.7.10.1
tropomyosin-related kinase-B, human
EC 2.7.10.1
BRAF protein, human
EC 2.7.11.1
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
989-1003Références
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Clin Transl Oncol. 2015 Feb;17(2):103-12
pubmed: 25351175
J Clin Oncol. 2018 Aug 1;36(22):2251-2258
pubmed: 29768118
Thorax. 2016 Feb;71(2):177-84
pubmed: 26530085
Cancer Treat Rev. 2018 May;66:82-94
pubmed: 29729495
Ann Oncol. 2018 Aug 1;29(8):1869-1876
pubmed: 29912274
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Ann Oncol. 2018 Jan 1;29(suppl_1):i10-i19
pubmed: 29462254
Arch Pathol Lab Med. 2018 Jul;142(7):796-797
pubmed: 29648886
Am J Surg Pathol. 2013 Sep;37(9):1441-9
pubmed: 23887156
Oncologist. 2018 Jun;23(6):740-745
pubmed: 29438093
J Clin Oncol. 2018 Mar 20;36(9):911-919
pubmed: 29401004
Cancer Cell. 2018 Nov 12;34(5):792-806.e5
pubmed: 30449325
J Thorac Oncol. 2015 Oct;10(10):1451-7
pubmed: 26200454
J Clin Oncol. 2008 Feb 20;26(6):983-94
pubmed: 18281673
Science. 2015 Apr 3;348(6230):124-8
pubmed: 25765070
Arch Pathol Lab Med. 2019 May;143(5):628-633
pubmed: 30576239
Cancer Cytopathol. 2018 Aug;126 Suppl 8:599-614
pubmed: 30156772
JCO Precis Oncol. 2018;2018:
pubmed: 30215037
Mod Pathol. 2019 Jan;32(1):147-153
pubmed: 30171197
Clin Cancer Res. 2017 Sep 1;23(17):4970-4979
pubmed: 28864725
Cancer Cytopathol. 2017 Dec;125(12):896-907
pubmed: 29024471
N Engl J Med. 2014 Nov 20;371(21):1963-71
pubmed: 25264305
Cancer Discov. 2018 Dec;8(12):1529-1539
pubmed: 30257958
Sci Rep. 2017 Feb 09;7:42259
pubmed: 28181564
J Mol Diagn. 2017 May;19(3):341-365
pubmed: 28341590
Clin Lung Cancer. 2018 Sep;19(5):387-394.e2
pubmed: 29656868
J Clin Oncol. 2015 Mar 20;33(9):992-9
pubmed: 25667280
J Clin Oncol. 2018 May 10;36(14):1405-1411
pubmed: 29596029
Nat Rev Clin Oncol. 2018 Mar;15(3):150
pubmed: 29182164
J Thorac Oncol. 2019 Mar;14(3):377-407
pubmed: 30572031
Ann Oncol. 2016 Sep;27 Suppl 3:iii16-iii24
pubmed: 27573752
Clin Cancer Res. 2015 Aug 15;21(16):3631-9
pubmed: 25567908
Cancer Cytopathol. 2018 May;126(5):342-352
pubmed: 29499101
J Thorac Oncol. 2018 Sep;13(9):1248-1268
pubmed: 29885479
Expert Rev Mol Diagn. 2016 Jun;16(6):707-13
pubmed: 27031368
Clin Cancer Res. 2018 Jul 1;24(13):3108-3118
pubmed: 29530932
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
J Thorac Oncol. 2016 Jul;11(7):964-75
pubmed: 27117833
J Clin Pathol. 2013 Aug;66(8):705-7
pubmed: 23618692
Oncologist. 2016 Jun;21(6):762-70
pubmed: 27245569
Nat Med. 2018 May;24(5):638-646
pubmed: 29686424
Am J Surg Pathol. 2017 Nov;41(11):1547-1551
pubmed: 28719467
Ann Oncol. 2019 Feb 1;30(2):161-165
pubmed: 30624547
Arch Pathol Lab Med. 2017 Sep;141(9):1195-1213
pubmed: 28644685
ESMO Open. 2019 Jan 24;4(1):e000442
pubmed: 30792906
Clin Transl Oncol. 2013 Jul;15(7):503-8
pubmed: 23359174
N Engl J Med. 2009 Sep 3;361(10):958-67
pubmed: 19692684
Clin Chem. 2017 Mar;63(3):751-760
pubmed: 28073897
J Thorac Oncol. 2015 Oct;10(10):1396-403
pubmed: 26301799
Clin Cancer Res. 2019 Jan 1;25(1):64-72
pubmed: 30206164
Clin Transl Oncol. 2012 May;14(5):338-49
pubmed: 22551539
Histopathology. 2018 Jan;72(2):270-284
pubmed: 28815764
J Thorac Oncol. 2018 Oct;13(10):1474-1482
pubmed: 29935306
Arch Pathol Lab Med. 2016 Jun 22;140(11):1191-1199
pubmed: 27333361
Br J Cancer. 2014 May 27;110(11):2812-20
pubmed: 24743704
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
Arch Pathol Lab Med. 2016 Jan;140(1):29-40
pubmed: 25965939
Arch Pathol Lab Med. 2018 Mar;142(3):321-346
pubmed: 29355391
J Clin Oncol. 2016 Mar 1;34(7):721-30
pubmed: 26729443
J Clin Oncol. 2017 Dec 1;35(34):3867-3876
pubmed: 29053400
N Engl J Med. 2018 May 31;378(22):2093-2104
pubmed: 29658845
Curr Oncol. 2017 Apr;24(2):103-110
pubmed: 28490924
Arch Pathol Lab Med. 2018 Mar;142(3):408-419
pubmed: 28686497
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
Cancer Discov. 2017 Feb;7(2):137-155
pubmed: 28122866
Arch Pathol Lab Med. 2018 Sep;142(9):1127-1133
pubmed: 29547001
J Thorac Oncol. 2018 Dec;13(12):1897-1905
pubmed: 30096481
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
J Thorac Oncol. 2019 Dec;14(12):2120-2132
pubmed: 31349061
PLoS One. 2012;7(8):e43842
pubmed: 22952784
Virchows Arch. 2016 Nov;469(5):489-503
pubmed: 27535289
Arch Pathol Lab Med. 2019 Jun;143(6):670-676
pubmed: 29372844
J Thorac Dis. 2018 Apr;10(Suppl 7):S882-S897
pubmed: 29780635
Clin Cancer Res. 2019 Jul 1;25(13):3753-3758
pubmed: 30787022
Am J Surg Pathol. 2008 Sep;32(9):1317-21
pubmed: 18636014
JAMA Oncol. 2018 Sep 1;4(9):1189-1197
pubmed: 29902295
Arch Pathol Lab Med. 2018 Mar;142(3):291-298
pubmed: 29494220
Ann Oncol. 2019 Sep 1;30(9):1417-1427
pubmed: 31268127
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
J Clin Oncol. 2018 Aug 20;36(24):2532-2537
pubmed: 29989854
J Thorac Oncol. 2014 Nov;9(11):1714-9
pubmed: 25436805
ESMO Open. 2019 Apr 20;4(2):e000516
pubmed: 31233036
PLoS One. 2014 Sep 23;9(9):e107200
pubmed: 25248157
Cancer Discov. 2015 Aug;5(8):842-9
pubmed: 25971939
Cancer Cytopathol. 2017 Aug;125(8):615-626
pubmed: 28475299
Mod Pathol. 2014 May;27(5):711-20
pubmed: 24186139
Clin Cancer Res. 2019 Aug 1;25(15):4712-4722
pubmed: 31028088
Histopathology. 2018 Jul;73(1):19-28
pubmed: 29464758
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
Oncologist. 2015 Oct;20(10):1175-81
pubmed: 26330460
Lung Cancer. 2018 Oct;124:53-64
pubmed: 30268480
Arch Pathol Lab Med. 2016 Aug;140(8):825-9
pubmed: 27195432